BN Business News
Add your company to Business Communicator →

Prawo i regulacje · 25/05/2023

Galephar Pharmaceuticals Research, Inc. Seeks Registration as Controlled Substance Importer

Galephar Pharmaceuticals Research, Inc. has submitted a request to the authorities to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry.

Source: Federal Register — Justice DepartmentOpen original release →